Early-Stage Anti-Inflammation drug trial halted after testing in healthy volunteers
Knowledge-focused
Terminated
This was the first human study of an experimental drug called iCP-NI, designed to block inflammation at the cellular level. Researchers tested single and multiple doses in 24 healthy adults to check for safety, side effects, and how the body processes the drug. The study was term…
Phase: PHASE1 • Sponsor: Cellivery Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC